Analyst Ratings for Kindred Biosciences (KIN)

KIN Rating Summary

  |   Expand Research on KIN
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 2 / 10   Percentile Rank: 15%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/23/2021 Alliance Global Partners Ben Haynor Downgrade Neutral
(Buy)		 9.25
(N/A)		 9.23
(9.25)		 0.22% Details
6/17/2021 Lake Street N/A Downgrade Hold
(Buy)		 N/A
(N/A)		 9.23
(9.25)		 0.22% Details